For a better understanding of the role of IGFBP7 in bone metabolism, we used both in vitro and in vivo studies to investigate the effects of IGFBP7 on RANKL‐induced osteoclastogenesis and osteoporosis and characterized the underlying molecular mechanisms of these processes. Here, IGFBP7 is linked to osteoporosis.